GOG-0238

A Randomized Trial of Pelvic Irradiation with or Without Concurrent Weekly Cisplatin in Patients with Pelvic-Only Recurrence of Carcinoma of the Uterine Corpus

Principal Investigator

Jonathan Michael Feddock

Status

Disease Site

Gynecologic [GY] Uterine Corpus

Phase

II

Developmental Therapeutics

No

Primary Objective

To assess whether pelvic radiation therapy with concurrent cisplatin is more promising with respect to progression-free survival than pelvic radiation therapy alone in the treatment of recurrent uterine carcinoma limited to the pelvis and vagina.

 

Patient Population

Pelvic radiation therapy with concurrent cisplatin or pelvic radiation therapy alone in the treatment of recurrent uterine carcinoma limited to the pelvis and vagina.

Target Accrual

154